Corbus Pharmaceuticals
CRBP
CRBP
105 hedge funds and large institutions have $168M invested in Corbus Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 103 → 105 (+2)
0.05% less ownership
Funds ownership: 1.64% → 1.59% (-0.05%)
62% less call options, than puts
Call options by funds: $587K | Put options by funds: $1.54M
Holders
105
Holding in Top 10
2
Calls
$587K
Puts
$1.54M
Top Buyers
| 1 | +$1.6M | |
| 2 | +$776K | |
| 3 | +$436K | |
| 4 |
GAI
General American Investors
New York
|
+$410K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$376K |
Top Sellers
| 1 | -$6.06M | |
| 2 | -$2.57M | |
| 3 | -$681K | |
| 4 |
Morgan Stanley
New York
|
-$648K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$628K |